Pathelium is a pioneering biotech startup focused on unlocking the regenerative potential of epithelial tissues to treat and cure chronic diseases. Our science is built on the insight that over 70% of chronic diseases (such as IBP,COPD, and fibrosis) begin with epithelial dysfunction—the body's first line of defense across the skin, lungs, and intestines. Where big pharmas treat symptoms, generic stem cells lack precision, and tissue engineers miss function, we are pioneering in rebuilding the body's critical barrier to cure disease, not manage it.
Company Details
- Employees
- 1
- Founded
- 2025
- Address
- Miami, Florida 34293, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.pathelium.com
- Keywords
- Regenerative Medicine, Epithelial Stem Cell Technology, ECM Scaffolding, Gene Editing, AI-Driven Biomaterials, CRISPR Gene Editing, Precision Medicine, Chronic Diseases, Corneal Regeneration.
- HQ
- Miami, Florida
Pathelium Questions
Pathelium's website is https://www.pathelium.com
Pathelium's LinkedIn profile is https://www.linkedin.com/company/pathelium
Pathelium has
1 employees.
View email and phone details for 1
employees at Pathelium.
Pathelium's industry is
Biotechnology Research
Pathelium's top competitors are
Ready When You Are,
Newlimit,
Seven Seven Six 7️⃣7️⃣6️⃣,
Waffle (Yc X25),
Xaira Therapeutics,
Altos Labs,
Endpoints News,
Bionaut Labs,
Breakthrough Genomics,
Beep Electric.
Pathelium's categories are Biotechnology Research
Pathelium's founding year is 2025
